EUVIMEDEUVIMED entdecken
Multizentrische Studie

Pregnancy‐associated melanoma epidemiology: A multicentre European study

Maria Kostaki iD, Michaela Plaka, Vasiliki Chardalia, Katerina Kypreou, Christina Nikolaou, Liberis Louros, Stefanos Tsallas, Irene Gamatsi, Laura Del Regno, Lucia Di Nardo iD, Ketty Peris iD, Nika Franceschi iD und 7 weitere

Journal of the European Academy of Dermatology and Venereology · 2026-05 · 40 (5) · 835-840

DOI: 10.1111/jdv.70134 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 24.10.2025. Verfasst von Maria Kostaki und 18 weiteren Autor:innen. Beteiligte Einrichtung: General Hospital of Athens G. Gennimatas, Plastic Surgery, Microsurgery Burns and Melanoma Referral Center, Athens, Greece. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma is the most common malignancy during pregnancy, with incidence rates rising globally. While most studies focus on prognosis, limited data exist on melanoma in the early post‐partum period.

Objectives

This multicentre European study aimed to characterize the epidemiologic and clinicopathologic features of pregnancy‐associated melanoma (PAM) and assess whether these tumours differ from melanomas not associated with pregnancy.

Methods

We identified 1,270 women of reproductive age (15–49 years) diagnosed with melanoma between 2012 and 2022 across six melanoma centres in five European countries.

Results

Among them, 70 cases (5.5%) were classified as PAM (range: 1.2%–14.3%). Compared to non‐PAM patients, women with PAM were younger (mean age 35.7 years; p < 0.001) and more likely to have a high nevus count ( p = 0.031). The majority of PAMs (80.0%) were superficial spreading, and mean Breslow thickness was 1.16 mm; 12.9% were ulcerated. Notably, 57.1% developed on a pre‐existing nevus. Histopathologic features were similar between groups, except for tumour‐infiltrating lymphocytes (TILs): non‐PAM tumours exhibited significantly more dense TILs ( p = 0.012), possibly indicating a stronger immune response. Median follow‐up was 5.5 years. Recurrence‐free survival did not significantly differ between groups; the 5‐year recurrence‐free survival rate was 95%.

Conclusions

Although pregnancy does not appear to adversely impact melanoma prognosis, PAM demonstrates some distinct clinical features that warrant further investigation given the fact that it affects a substantial proportion of women of reproductive age diagnosed with melanoma. The frequent occurrence of PAM on pre‐existing nevi highlights the importance of raising public awareness and promoting dermatologic evaluation of suspicious lesions during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsPregnancy Complications, NeoplasticHumansFemaleAdultPregnancyEuropeMiddle AgedAdolescentYoung AdultIncidence

Stichwörter der Autor:innen

melanomanevuspregnancypregnancy‐associated melanomaskin neoplasmssurvival analysis

Autor:innen und Institutionen

  • General Hospital of Athens G. Gennimatas, Plastic Surgery, Microsurgery Burns and Melanoma Referral Center, Athens, Greece.
  • Andreas Syggros Hospital, First Department of Dermatology-Venereology of National and Kapodistrian University of Athens, Melanoma and Skin Cancer Center, Athens, Greece.
  • Universita Cattolica and Fonfazione Policlinico, Universitario A. Gemelli, Institute of Dermatology, Rome, Italy.
  • Department of Dermatology and Venereology, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
  • Department of Dermatology, Elias University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Department of Dermatology, University of Belgrade, Faculty of Medicine, Belgrade, Serbia.

ORCID-Profile: Maria Kostaki, Lucia Di Nardo, Ketty Peris, Nika Franceschi, Alexandra Dobre, Ana-Maria Forsea, Lidija Kandolf Sekulovic

Zitieren

APA

Kostaki, M., Plaka, M., Chardalia, V., Kypreou, K., Nikolaou, C., Louros, L., Tsallas, S., Gamatsi, I., Del Regno, L., Di Nardo, L., Peris, K., Franceschi, N., Duvancic, T., Situm, M., Dobre, A., Forsea, A. M., Radevic, T., Sekulovic, L. K., & Stratigos, A. (2026). Pregnancy‐associated melanoma epidemiology: A multicentre European study. Journal of the European Academy of Dermatology and Venereology, 40(5), 835-840. https://doi.org/10.1111/jdv.70134

Vancouver

Kostaki M, Plaka M, Chardalia V, Kypreou K, Nikolaou C, Louros L, et al. Pregnancy‐associated melanoma epidemiology: A multicentre European study. Journal of the European Academy of Dermatology and Venereology. 2026;40(5):835-840. doi:10.1111/jdv.70134

BibTeX
@article{Kostaki2026,
  author = {Kostaki, Maria and Plaka, Michaela and Chardalia, Vasiliki and Kypreou, Katerina and Nikolaou, Christina and Louros, Liberis and Tsallas, Stefanos and Gamatsi, Irene and Del Regno, Laura and Di Nardo, Lucia and Peris, Ketty and Franceschi, Nika and Duvancic, Tomislav and Situm, Mirna and Dobre, Alexandra and Forsea, Ana-Maria and Radevic, Tatjana and Sekulovic, Lidija Kandolf and Stratigos, Alexander},
  title = {Pregnancy‐associated melanoma epidemiology: A multicentre European study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {5},
  pages = {835--840},
  doi = {10.1111/jdv.70134}
}
Kostenlos starten →